AZN
AstraZeneca PLC
NASDAQ: AZN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$187.37
+1.17% today
Updated 2026-04-30
Market cap
$294.17B
P/E ratio
28.97
P/S ratio
5.01x
EPS (TTM)
$6.55
Dividend yield
1.66%
52W range
$130 – $211
Volume
2.0M
AstraZeneca PLC (AZN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.48B | $29.56B | $31.60B | $32.80B | $33.27B | $33.59B | $27.97B | $25.81B | $26.55B | $24.71B | $23.00B | $22.46B | $22.09B | $24.38B | $26.62B | $37.42B | $44.35B | $45.81B | $54.07B | $58.74B |
| Revenue growth (YoY) | — | +11.6% | +6.9% | +3.8% | +1.4% | +1.0% | -16.7% | -7.7% | +2.9% | -6.9% | -6.9% | -2.3% | -1.7% | +10.4% | +9.2% | +40.6% | +18.5% | +3.3% | +18.0% | +8.6% |
| Cost of revenue | $5.56B | $6.42B | $6.60B | $5.78B | $6.39B | $6.03B | $5.39B | $5.26B | $5.84B | $4.65B | $4.13B | $4.32B | $4.94B | $4.92B | $5.30B | $12.44B | $12.39B | $8.27B | $10.21B | $10.63B |
| Gross profit | $20.92B | $23.14B | $25.00B | $27.03B | $26.88B | $27.57B | $22.58B | $20.55B | $20.70B | $20.06B | $18.88B | $18.15B | $17.15B | $19.46B | $21.32B | $24.98B | $31.96B | $37.54B | $43.87B | $48.11B |
| Gross margin | 79.0% | 78.3% | 79.1% | 82.4% | 80.8% | 82.1% | 80.7% | 79.6% | 78.0% | 81.2% | 82.1% | 80.8% | 77.7% | 79.8% | 80.1% | 66.8% | 72.1% | 82.0% | 81.1% | 81.9% |
| R&D | $3.90B | $5.16B | $5.18B | $4.41B | $5.32B | $5.52B | $5.24B | $4.82B | $5.58B | $6.00B | $5.89B | $5.76B | $5.93B | $6.06B | $5.99B | $9.74B | $9.76B | $10.94B | $13.58B | $14.23B |
| SG&A | $9.32B | $10.61B | $10.91B | $11.33B | $10.45B | $11.16B | $9.84B | $12.21B | $13.00B | — | $9.41B | $10.23B | — | — | — | $15.14B | $17.45B | $17.68B | $19.67B | $19.93B |
| Operating income | $8.22B | $8.09B | $9.14B | $11.54B | $11.49B | $12.79B | $8.15B | $3.71B | $2.14B | $4.11B | $4.90B | $3.68B | $3.39B | $2.92B | $5.16B | $1.06B | $3.76B | $8.19B | $10.00B | $13.74B |
| Operating margin | 31.0% | 27.4% | 28.9% | 35.2% | 34.5% | 38.1% | 29.1% | 14.4% | 8.0% | 16.7% | 21.3% | 16.4% | 15.3% | 12.0% | 19.4% | 2.8% | 8.5% | 17.9% | 18.5% | 23.4% |
| EBITDA | $9.56B | $9.95B | $12.62B | $13.95B | $14.74B | $15.39B | $10.68B | $8.34B | $5.49B | $6.96B | $7.28B | $6.62B | $7.11B | $6.71B | $8.08B | $5.11B | $9.09B | $13.42B | $15.44B | $19.83B |
| EBITDA margin | 36.1% | 33.7% | 39.9% | 42.5% | 44.3% | 45.8% | 38.2% | 32.3% | 20.7% | 28.2% | 31.6% | 29.5% | 32.2% | 27.5% | 30.4% | 13.7% | 20.5% | 29.3% | 28.6% | 33.8% |
| EBIT | $8.22B | $8.09B | $10.00B | $11.86B | $12.00B | $12.84B | $8.16B | $3.76B | $2.21B | $4.11B | $4.92B | $3.59B | $3.36B | $2.95B | $5.19B | $1.01B | $3.83B | $8.49B | $10.37B | $14.10B |
| Interest expense | — | — | $1.32B | $1.05B | $1.02B | $554.00M | $519.00M | $492.00M | $963.00M | $1.04B | $1.37B | $1.36B | $1.37B | $1.40B | $1.27B | $1.28B | $1.33B | $1.59B | $1.68B | $1.69B |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $6.04B | $5.59B | $6.10B | $7.52B | $8.05B | $9.92B | $6.24B | $2.56B | $1.23B | $2.83B | $3.50B | $3.00B | $2.15B | $1.33B | $3.20B | $112.00M | $3.29B | $5.96B | $7.04B | $10.26B |
| Net income growth (YoY) | — | -7.4% | +9.0% | +23.3% | +7.1% | +23.1% | -37.1% | -59.0% | -51.8% | +129.1% | +23.9% | -14.2% | -28.2% | -38.1% | +139.4% | -96.5% | +2835.7% | +81.1% | +18.1% | +45.8% |
| Profit margin | 22.8% | 18.9% | 19.3% | 22.9% | 24.2% | 29.5% | 22.3% | 9.9% | 4.6% | 11.4% | 15.2% | 13.4% | 9.8% | 5.5% | 12.0% | 0.3% | 7.4% | 13.0% | 13.0% | 17.5% |